7 Participants NeededMy employer runs this trial
KB111 for Benign Familial Pemphigus
(HALITE-1 Trial)
BA
Overseen ByBrittani Agostini
Age: Any Age
Sex: Any
Trial Phase: Phase < 1
Sponsor: Krystal Biotech, Inc.
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
What You Need to Know Before You Apply
What is the purpose of this trial?
An open-label study to evaluate the safety and efficacy of KB111 in pediatric and adult subjects with Hailey-Hailey Disease
Are You a Good Fit for This Trial?
Inclusion Criteria
A negative pregnancy test prior to initial dose for subjects of child-bearing potential
I have been on the same dose of my systemic therapy for at least 1 month.
An acceptable form of contraception must be taken from the first dose (Week 1) through 3 months after the last dose of IP for subjects of childbearing potential
See 3 more
Exclusion Criteria
Presence of any dermatologic or systemic condition that might hinder the efficacy of the study treatment or its evaluation, could possibly interfere with the interpretation of study results, or could be judged by the Investigator to be incompatible with the study visit schedule or conduct
Participant who is pregnant or nursing
Participant who is unwilling to comply with contraception requirements per protocol (for subjects of child-bearing potential)
See 2 more
What Are the Treatments Tested in This Trial?
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Group I: KB111Experimental Treatment1 Intervention
KB111
Find a Clinic Near You
Who Is Running the Clinical Trial?
Krystal Biotech, Inc.
Lead Sponsor
Trials
15
Recruited
770+
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.